Context Therapeutics

CNTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$35.750 M

$0.39 +3.87%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$36.1M

Loss-making

Shares outstanding

91,879,177

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#369Mira PharmaceuticalsMIRA$38.1M
#370Actinium PharmaceuticalsATNM$36.8M
#371Context TherapeuticsCNTX$35.8M
#372Rockwell MedicalRMTI$35.7M
#373BriaCell TherapeuticsBCTX$35.6M

What if Context Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$329,062.26

Per share 845,701× higher

Bitcoin $1.74T

$18,955.93

Per share 48,717× higher

Nvidia $5.52T

$60,032.83

Per share 154,286× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Context Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.